<SEC-DOCUMENT>0000903423-19-000003-index.html : 20190103
<SEC-HEADER>0000903423-19-000003.hdr.sgml : 20190103
<ACCEPTANCE-DATETIME>20190103172133
ACCESSION NUMBER:		0000903423-19-000003
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20190103
DATE AS OF CHANGE:		20190103

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Urovant Sciences Ltd.
		CENTRAL INDEX KEY:			0001740547
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90671
		FILM NUMBER:		19507022

	BUSINESS ADDRESS:	
		STREET 1:		5151 CALIFORNIA AVENUE
		STREET 2:		SUITE 250
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92617
		BUSINESS PHONE:		949-226-6029

	MAIL ADDRESS:	
		STREET 1:		5151 CALIFORNIA AVENUE
		STREET 2:		SUITE 250
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92617

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VIKING GLOBAL INVESTORS LP
		CENTRAL INDEX KEY:			0001103804
		IRS NUMBER:				134055118
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		55 RAILROAD AVENUE
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
		BUSINESS PHONE:		212-672-7050

	MAIL ADDRESS:	
		STREET 1:		55 RAILROAD AVENUE
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>urovant13da1.htm
<TEXT>
Document 1 - file: urovant13da1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>urovant13daex991.htm
<TEXT>
Document 2 - file: urovant13daex991.htm

</DOCUMENT>
</SEC-DOCUMENT>